An observational study in Qualitative Research, sponsored by Istanbul Esenyurt University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-09.
Sponsored by Istanbul Esenyurt University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 133 studies in Asthma with a site in Turkey — 16 open to participants now, 21 under way, 5 of them phase 3. Asthma · Turkey.
Among the 133 studies in Asthma with a site in Turkey, this one is the 20th largest by planned enrollment of the 21 observational ones that give a count, is one of 11 that started in 2026, is one of 21 observational ones, reaches primary completion later than 8 of the 20 other live ones, and was the 119th registered.
4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.
Browse Asthma studies →16 of the 133 studies in Asthma with a site in Turkey are open now. Recruiting first, the newest first:
Antalya Health Sciences University · Sites in Turkey
Ages 8–17
AstraZeneca · Sites in Turkey, United States, Argentina and 11 more countries
Ages 6+
Bezmialem Vakif University · Sites in Turkey
Ages 10–17
Generate Biomedicines · Sites in Turkey, United States, Argentina and 16 more countries
Ages 12–80
AstraZeneca · Sites in Turkey, United States, Argentina and 18 more countries
Ages 18–75
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
133 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 11 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 15 is below the median of 159 across 1,254 observational studies indexed under Asthma.
Median enrollment 119 across the 112 interventional studies, 95 across the 21 observational. Of the 104 that completed or were terminated, 36 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
54 of 133 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Istanbul Esenyurt University as lead sponsor.
Istanbul Esenyurt University has 1 study filed under Asthma — fewer than ten, so there is no comparison to draw.
9 of the studies in Asthma with a site in Turkey that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05757102Phase 3GlaxoSmithKlineA Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma | 2027-01-26 |
| NCT07880145Hasan Kalyoncu UniversityEffects of Respiratory Muscle Strength Training in Children With Asthma | 2027-01 |
| NCT07320066Istanbul Esenyurt UniversityIMT in Asthma: Activity, Coping, Self-Management | 2027-01-01 |
| NCT05097287SanofiStudy Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma | 2027-03-16 |
| NCT06796894Hacettepe UniversitySymptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics | 2027-03-30 |
Add all 9 to your calendar (.ics) → With an account.
Among the 133 studies in Asthma with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to investigate asthma patients' experiences with an 8 week IMT and the perceived effects of this intervention on physical activity, coping strategies, and asthma self-management. A qualitative methodological design will be applied to understand the experiences of patients participating in the IMT program, how the program affected their daily activities, how they coped with symptoms and difficulties, and how they managed their condition.
The study will include patients diagnosed with asthma by a chest disease specialist and referred for pulmonary rehabilitation. Cases meeting the inclusion criteria will be questioned about the effects of their previous experience with COPD on their daily lives, their coping strategies, and their self-management processes. Therefore, it is determined as a basic criterion that participants have received IMT training for 8 weeks, 2 days a week via video conference and 1 day within the home program, for a total of 3 days a week. IMT should be performed in 7 sets, consisting of 2 minutes of work and 1 minute of rest, for a total of 21 minutes. Five main themes were identified as a result of data analysis. (a) Inspiratory Muscle Training and Participant Experiences (b) Experience of Exercising with Telerehabilitation (c) Changes in Physical Activity Levels (d) Self-Management Skills and (e) Coping Strategies.
Asthma
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
FEV1
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Pulmonary Rehabilitation Group (PRGr) Participant selection for the study was conducted using a purposive sampling approach. All participants experienced inspiratory muscle training for a total of 3 days per week over 8 weeks, with 2 days per week via video conference and 1 day per week as part of a home program. All interviews will be conducted online via a video conference website and recorded using a digital voice recorder. The recorded data will be transcribed word for word in Turkish.
Other: other
Other: Telephone concept elicitation interview All interview questions are designed to be quite open-ended in order to determine participants' preferences in an unbiased manner (as much as possible). Additional questions will only be used when necessary to ensure that all relevant concepts are covered. Participants will be asked questions about the effects of inspirational muscle training they have previously experienced on their daily lives, coping strategies, and self-management processes.
Patient-reported experiences of inspiratory muscle training (IMT) assessed by semi-structured in-depth interviews (study-specific interview guide)
Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide containing open-ended questions to investigate the effect of an 8-week inspiratory muscle training (IMT) program on the experiences of adults with severe persistent asthma. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.
Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)
Experience of exercising using telerehabilitation assessed by semi-structured in-depth interviews (study-specific interview guide)
Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide with open-ended questions to explore participants' experiences of exercising with telerehabilitation, including the perceived role of telerehabilitation in the learning process, and perceived advantages, limitations, and challenges from the participant's perspective. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.
Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)
Changes in physical activity in daily life assessed by semi-structured in-depth interviews (study-specific interview guide)
Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide with open-ended questions to explore perceived changes in physical activity in daily life (e.g., walking, climbing stairs, housework) from the participant's perspective following the 8-week program. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.
Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)
Self-management skills assessed by semi-structured in-depth interviews (study-specific interview guide)
Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide with open-ended questions to explore participants' perceived self-management skills, including disease and trigger recognition, symptom monitoring, accountability/responsibility, and perceived control. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.
Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)
Coping strategies assessed by semi-structured in-depth interviews (study-specific interview guide)
Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide with open-ended questions to explore participants' perceived coping strategies, including breathing/respiratory rate control strategies and emotional and behavioral regulation during symptom attacks and when anxiety/panic symptoms are prominent. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.
Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 11 months after the start.
Of 366 non-industry observational studies under Asthma, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 97. This study's planned 11 months is below that.
Counting every sponsor, half of 456 studies reached it within 36 months; a quarter within 18 and three quarters within 82.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.